Expanding the Benefit: Dabrafenib/Trametinib as Tissue-Agnostic Therapy for

United States Humans Adult Child Carcinoma, Non-Small-Cell Lung Proto-Oncogene Proteins B-raf / genetics Lung Neoplasms Glioma

Journal

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
ISSN: 1548-8756
Titre abrégé: Am Soc Clin Oncol Educ Book
Pays: United States
ID NLM: 101233985

Informations de publication

Date de publication:
May 2023
Historique:
medline: 11 5 2023
pubmed: 9 5 2023
entrez: 9 5 2023
Statut: ppublish

Résumé

The recent US Food and Drug Administration (FDA) approval of the dabrafenib/trametinib combination as a tissue-agnostic treatment for solid tumors with

Identifiants

DOI: 10.1200/EDBK_404770 PMID: 37159870
pubmed: 37159870
doi: 10.1200/EDBK_404770
doi:

Substances chimiques

Proto-Oncogene Proteins B-raf EC 2.7.11.1
dabrafenib QGP4HA4G1B
trametinib 33E86K87QN
BRAF protein, human EC 2.7.11.1

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e404770

Auteurs

Mohamed A Gouda (MA)

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Department of Clinical Oncology, Faculty of Medicine, Menoufia University, Shebin Al-Kom, Egypt.
ORCID: 0000-0003-4829-6739

Vivek Subbiah (V)

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
MD Anderson Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, TX.
ORCID: 0000-0002-6064-6837

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Régions géographiques › Amériques › Amérique du Nord › États-Unis › Expanding the Benefit: Dabrafenib/Trametinib...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Expanding the Benefit: Dabrafenib/Trametinib...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Expanding the Benefit: Dabrafenib/Trametinib...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Expanding the Benefit: Dabrafenib/Trametinib...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Tumeurs des bronches › Carcinome bronchogénique › Carcinome pulmonaire non à petites cellules › Expanding the Benefit: Dabrafenib/Trametinib...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines tumorales › Protéines oncogènes › Protéines proto-oncogènes › Kinases raf › Protéines proto-oncogènes B-raf › Expanding the Benefit: Dabrafenib/Trametinib...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Expanding the Benefit: Dabrafenib/Trametinib...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroépitheliales › Gliome › Expanding the Benefit: Dabrafenib/Trametinib...